Pierre Dodion

Pierre is a senior pharmaceutical executive with over 30 years of global experience, with an extensive expertise in oncology. He supports clients across a range of functional disciplines, including clinical, regulatory, manufacturing, quality, strategic market access, commercial and M&A. He most recently served as executive vice president and chief medical officer at Innate Pharmaceuticals, where he provided strategic oversight and overall coordination of clinical development, medical affairs, biostatistics, clinical operations and safety of several oncology programs. Previously, Pierre held similar leadership roles at Aventis, Novartis, Pfizer, and ARIAD.

Pierre brings significant expertise in clinical development and medical affairs. He is familiar with the regulatory frameworks in both the US and the European Union. During his career he has set up and executed numerous clinical trials, Phases I - IV, including company-, investigator- and cooperative-group sponsored trials, and has led several projects that have achieved global approvals.

Pierre also works with clients on business and corporate development, strategic planning, product evaluation, partnerships, and organic expansion (US, Canada, Europe, Australia, Japan).